Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Nov / Extraterrestrial Risk
Discovery & Development Drug Delivery

Extraterrestrial Risk

By Stephanie Vine 11/20/2020 1 min read Longer Read (pre 2022)

Share

What biosecurity risks do exo-microorganisms pose? Neil Gow, Deputy Vice-Chancellor for Research and Impact, and a professor of microbiology at the University of Exeter, UK, and Mihai Netea, a professor at Radboud University Medical Center, the Netherlands, mulled the idea while walking on the beach at a scientific meeting in the Caribbean – and devised two potential studies on how to address the risks. The first of those studies was published earlier this year (1): “A Weakened Immune Response to Synthetic Exo-Peptides Predicts a Potential Biosecurity Risk in the Retrieval of Exo-Microorganisms.”

Discussing the work at an astrobiology conference in Seattle in 2019, Katja Schaefer, lead author on the study, discussed the field of exo-immunobiology  (originally introduced by Netea) – where the human immune system encounters either a completely alien microorganism, or Earth organisms that have been adapted to space environments. How would the immune system react? And would it even recognize the organisms to elicit an immune response?

Exo-microorganisms are not just a risk for those exploring space – they could be brought back to Earth during sample retrieval from exoplanets or moons, for example. Schaefer, Gow, Netea, and their co-authors believe that exo-microorganisms with distinct proteomes may present immunological challenges. Their study tested the mammalian immune response towards protein antigens containing two amino acids: isovaline and α-aminoisobutyric acid. Both are extremely rare in earth organisms, but have been identified in abundance in chondrite meteorites.

“My background actually lies in fungal pathogens, but when I started working with Neil Gow, he told me about his provocative ideas involving amino acids on meteorites – and it was interesting! We decided that I would start it as a side project to my main work,” says Schaefer. “Other papers have discussed the characterization of amino acids from meteorites, but to find out how they’d affect the immune response, a peptide was needed. I didn’t have an immunological background, so we brought in other collaborators. Once we had the peptide, we isolated immune cells from mice and measured the effect when they were exposed to the peptide.”

The result? The peptide was recognized by the immune system, which led to an immunological response, but T cell activation and proliferation were both significantly reduced compared with exposure to common peptides on Earth.

What does this mean for humans? It’s very difficult to say, but peptides or organisms made up of different amino acids to those on Earth could pose an immunological risk. “There are many other questions that we can also explore, such as why the immune response was low, what enzymes and processes are involved, and whether it is possible for the mammalian immune system to produce antibodies in response to the peptides,” says Schaefer.

The risk could also be greater for astronauts. Conditions in space can also change how the immune system works. Astronauts are exposed to very extreme environmental stresses, including microgravity, radiation, and poor nutrition – which can result in a weakened immune response, including reduced cytokine release and reduced T cell function (2). “This is already in effect without exposure to a pathogen – and also remains in effect for some time after the astronauts have returned to Earth,” explains Schaefer. “It would be interesting to do experiments with the immune cells of returning astronauts to see how the immune response changes when exposed to these rare amino acids. We also want to look at how the properties of terrestrial microbes could be altered by growing on exo-substrates. I’m also interested in the fact that different sugars have been found on meteorites – and, recently, a peptide. This is a vibrant area of research.”

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. K Schaefer et al., Microorganisms, 8 (2020). 
  2. MG Netea et al., PLOS Pathogens (2020).

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

Managing Change in Devices for Patients
Drug Delivery
Managing Change in Devices for Patients

June 21, 2024

4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want

Dosing to Circadian Rhythm
Drug Delivery
Dosing to Circadian Rhythm

December 1, 2014

0 min read

Could medicines be made more effective with better timing?

Connecting the Dots in Drug Delivery
Drug Delivery
Connecting the Dots in Drug Delivery

December 1, 2014

0 min read

The days of “low-hanging fruit” in drug discovery are a thing of the past...

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.